1,000
Participants
Start Date
November 14, 2022
Primary Completion Date
December 30, 2024
Study Completion Date
May 31, 2025
AROMHA Longitudinal Smell Test
The AROMHA Longitudinal Smell Test is a self-administered, at-home smell test intended for use as a screening test by asymptomatic individuals to help prevent exposure to and spread of SARS-CoV-2, the virus that causes COVID-19, through a serial testing approach. The device consists of six versions of a smell card, each containing three unique odors.
Massachusetts General Hospital, Boston
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Massachusetts General Hospital
OTHER